COVID-19 Vaccine Administration: Pharmacy Batch and Hard Copy Claims Can Be Submitted
January 19, 2021
Updated on March 3, 2021
Note:
Most recent updates are denoted with two plus signs (++)
This is the tenth article in the COVID-19 Vaccine Administration series and informs pharmacy providers that they may begin submitting NCPDP 1.2 transactions using Computer Media Claims (CMC) and hard copy (Pharmacy Claim Form [30-1]) claims.
++The Food and Drug Administration (FDA) had provided Emergency Use Authorization (EUA) for the following vaccine manufacturers:
As other vaccine manufacturers are approved by the FDA, additional billing instructions will be issued. Providers should refer to the COVID-19 Medi-Cal Response page for specific billing information for approved vaccines.
For the most current direction regarding whether or not claims should be submitted, and what behavior to expect when submitting, providers should refer to the “Pharmacy Claim Submissions” and “Medical and Outpatient Claim Submissions” tables on the COVID-19 Medi-Cal Response page.
